BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Business

  Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

  October 3, 2024

   · 

  1 min read
• Drug Development

  Summit Therapeutics Announces Completion of Enrollment in Its Phase III HARMONi Trial in 2L+ EGFRm NSCLC

  October 3, 2024

   · 

  14 min read
• Business

  GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024

  October 3, 2024

   · 

  1 min read
• News

  Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference

  October 3, 2024

   · 

  1 min read
• Drug Development

  Ultragenyx Provides Update on Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease

  October 3, 2024

   · 

  7 min read
• Business

  Poseida Therapeutics Named to Newsweek’s List of the Top 200 America’s Most Loved Workplaces for 2024

  October 3, 2024

   · 

  4 min read
• FDA

  OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip

  October 3, 2024

   · 

  2 min read
• FDA

  U.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo for Resectable Non-Small Cell Lung Cancer (NSCLC)

  October 3, 2024

   · 

  19 min read
• Business

  MedMira Announces the appointment of Vice President of Commercial Operations

  October 3, 2024

   · 

  3 min read